Table 1.
Clinical characteristics and dopamine transporter binding to the striatal sub-regions.
Table 2.
Independent predictors of early non-motor burden in Parkinson’s disease.
Table 3.
Effect of early non-motor burden and dopamine transporter binding to the sensorimotor striatum on initial UPDRS-motor score.
Fig 1.
UPDRS-motor score and dopamine transporter (DAT) binding between the two groups.
HNM-PD (closed circle) showed higher UPDRS-motor scores than LNM-PD (open circle) at similar DAT level. However, group (HNM-PD, solid line/LNM-PD, dotted line) and DAT activity interaction was non-significant for UPDRS-motor scores.
Fig 2.
Levodopa-equivalent dose and follow-up duration between the two groups.
HNM-PD (closed circle) received higher levodopa-equivalent dose than LNM-PD (open circle) at similar follow-up duration. However, group (HNM-PD, solid line/LNM-PD, dotted line) and follow-up duration interaction was non-significant for levodopa-equivalent doses.